N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders - results of Trans Tasman Radiation Oncology group study 98.02

Head and Neck

Volumn 30, Issue 6, 2008, Pages 737-742

  Corry, June ^a,b   Peters, Lester ^a,b   Fisher, Richard ^a,b   Macann, Andrew ^c   Jackson, Michael ^d   McClure, Bev ^a   Rischin, Danny ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Concurrent chemoradialion; Head and neck cancer; Neck dissection; Neck management

Indexed keywords

CISPLATIN; FLUOROURACIL; TIRAPAZAMINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NECK DISSECTION; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TREATMENT FAILURE;

EID: 46249103254     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20769     Document Type: Article

References (28)

1. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-2086.
2. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-1324.
3. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986;12:733-740.
4. Boyd TS, Harari PM, Tannehill SP, et al. Planned post-radiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998;20:132-137.
5. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
6. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2000;126:950-956.
7. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-566.
8. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999; 125:401-405.
9. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406.
10. Kuntz AL, Weymuller EA. Impact of neck dissection on quality of life. Laryngoscope 1999;109:1334-1338.
11. Rischin D, Peters LJ, Fisher R, et al. Tirapazamine, cis-platin and radiation versus fluorouracil, cisplatin and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 2005;23:79-87.
12. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Controlled Clin Trials 1996; 17:343-346.
13. Peters LJ, Weber RS, Morrison WH, et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-559.
14. Garden AS, Glisson BS, Ang KK, et al. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 1999;17:2390-2395.
15. Johnson CR, Silverman LN, Clay LB, Schmidt-Ullrich R. Radiotherapeutic management of bulky cervical lymph-adenopathy in squamous cell carcinoma of the head and neck: is post radiotherapy neck dissection necessary? Radiat Oncol Inv 1998;6:52-57.
16. Armstrong J, Pfister D, Strong E, et al. The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Biol Phys 1993;26: 759-765.
17. Thomas GR, Greenberg J, Wu KT, et al. Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy. Laryngoscope 1997; 107:1129-1137.
18. Sanguinetti G, Corvo R, Benasso M, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999;21: 223-238.
19. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemo-radiation for advanced head and neck cancer. Int J Radiat Biol Phys 2004;58:1418-1423.
20. Corry J, Smith JG, Peter LJ. The concept of a planned neck dissection is obsolete. Cancer J 2001;7:472-474.
21. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455.
22. Forest VI, Nguyen-Tan PF, Tabet JC, et al. Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma. Head Neck 2006;28: 1099-1105.
23. Chan AW, Ancukiewicz M, Carballo N, Montgomery W, Wang CC. The role of postradiotherpay neck dissection in supraglottic carcinoma. Int J Radiat Biol Phys 2001; 50:367-375.
24. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999;21:606-613.
25. Ware RE, Matthews JP, Hicks RJ, et al. Usefulness of fluorine- 18flurodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for SCC of the head and neck. Head Neck 2004;26:1004-1017.
26. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181.
27. Connell CA, Corry J, Milner AD, et al. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck 2007;29:986-995.
28. Yao M, Graham MM, Hoffman HT, et al. The role of post-radiation therapy FDG-PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head and neck squamous cell carcinoma. Int J Radiat Biol Phys 2004;59:1001-1010.